31 Apoptosis and radiation clonogenic survival in a solid tumor model system expressing BCL-2

Author(s):  
Marc S. Rudoltz ◽  
Eric J. Bernhard ◽  
Gary D. Kao ◽  
Vincent Baukanauskas ◽  
Ruth J. Muschel ◽  
...  
2020 ◽  
Vol 11 (1) ◽  
Author(s):  
Samantha D. Praktiknjo ◽  
Benedikt Obermayer ◽  
Qionghua Zhu ◽  
Liang Fang ◽  
Haiyue Liu ◽  
...  

2016 ◽  
Vol 2016 ◽  
pp. 1-16 ◽  
Author(s):  
Maria Abdul Ghafoor Raja ◽  
Haliza Katas ◽  
Zariyantey Abd Hamid

Penetration and distribution of drug through the avascular regions of human solid tumors after extravasation are crucial concerns for antitumor efficacy. To address this issue, anin vitrosolid tumor model of multicellular layers (MCLs) of human colorectal cancer cells (DLD-1) was established. In an attempt to deliver Dicer substrate small interfering RNA (DsiRNA), chitosan (CS) nanoparticles have been developed for targeting vascular endothelial growth factor (VEGF) gene for tumor growth inhibition. The DsiRNA-CS nanoparticles prepared by ionic gelation method had provided maximal protection of DsiRNA in full human serum up to 48 h incubation. RT-PCR studies revealed significant concentration- and time-dependent knock-down ofVEGFmRNA and its product due to uniform penetration of DsiRNA-CS nanoparticles throughout MCLs. Taken together, this study also demonstrated that DsiRNA-CS nanoparticles could effectively knock downVEGFgene as therapeutic target in monolayer culture or in solid tumor model for potential treatment of human colorectal carcinoma.


1993 ◽  
Vol 21 (6) ◽  
pp. 413-421 ◽  
Author(s):  
R. J. A. van Moorselaar ◽  
T. Ichikawa ◽  
H. E. Schaafsma ◽  
P. H. K. Jap ◽  
J. T. Isaacs ◽  
...  

1994 ◽  
Vol 86 (24) ◽  
pp. 1846-1852 ◽  
Author(s):  
J. J. Casciari ◽  
M. G. Hollingshead ◽  
M. C. Alley ◽  
J. G. Mayo ◽  
L. Malspeis ◽  
...  

2014 ◽  
Vol 66 (5) ◽  
pp. 835-848 ◽  
Author(s):  
Samarjit Jana ◽  
Kartick Patra ◽  
Shehnaz Sarkar ◽  
Jagannath Jana ◽  
Gopeswar Mukherjee ◽  
...  

Nanomaterials ◽  
2020 ◽  
Vol 10 (9) ◽  
pp. 1690
Author(s):  
Zbynek Novy ◽  
Volodymyr Lobaz ◽  
Martin Vlk ◽  
Jan Kozempel ◽  
Petr Stepanek ◽  
...  

Nanoparticles (NPs) represent an emerging platform for diagnosis and treatment of various diseases such as cancer, where they can take advantage of enhanced permeability and retention (EPR) effect for solid tumor accumulation. To improve their colloidal stability, prolong their blood circulation time and avoid premature entrapment into reticuloendothelial system, coating with hydrophilic biocompatible polymers is often essential. Most studies, however, employ just one type of coating polymer. The main purpose of this study is to head-to-head compare biological behavior of three leading polymers commonly used as “stealth” coating materials for biocompatibilization of NPs poly(ethylene oxide), poly(2-ethyl-2-oxazoline) and poly[N-(2-hydroxypropyl)methacrylamide] in an in vivo animal solid tumor model. We used radiolabeled biodegradable hydroxyapatite NPs as a model nanoparticle core within this study and we anchored the polymers to the NPs core by hydroxybisphosphonate end groups. The general suitability of polymers for coating of NPs intended for solid tumor accumulation is that poly(2-ethyl-2-oxazoline) and poly(ethylene oxide) gave comparably similar very good results, while poly[N-(2-hydroxypropyl)methacrylamide] was significantly worse. We did not observe a strong effect of molecular weight of the coating polymers on tumor and organ accumulation, blood circulation time, biodistribution and biodegradation of the NPs.


1993 ◽  
Vol 149 (1) ◽  
pp. 179-182 ◽  
Author(s):  
E.B. Cornel ◽  
R.J.A. Van Moorselaar ◽  
P. Van Stratum ◽  
F.M.J. Debruyne ◽  
J.A. Schalken

Sign in / Sign up

Export Citation Format

Share Document